Business Services Industry
Fitch Updates Cash Flow Modeling & NIMs Criteria for U.S. RMBS
Business Wire, Sept 5, 2006
NEW YORK -- Fitch Ratings has updated its cash flow modeling criteria for rating U.S. residential mortgage-backed securities (RMBS) and net interest margin (NIM) securitizations, effective immediately. Fitch's new criteria is implemented using the INTEX DealMaker structure modeling system.
As detailed in the July 18 report, 'U.S. RMBS Cash Flow Modeling Criteria', the revised criteria updates Fitch's assumptions for prepayments, loss distribution, and interest rates used when rating deals with senior-subordinate/overcollateralization (senior-sub/OC) structures that are typical in subprime and, more recently, in some Alt-A securitizations. Fitch's cash flow assumptions are based on mortgage performance data and give consideration to historical and projected market conditions.
In conjunction with the new criteria, Fitch has also announced that it has adopted the industry standard deal modeling tool, INTEX DealMaker. INTEX DealMaker provides a new level of transparency in Fitch's interaction with underwriters and issuers on the development of new structures.
Senior-sub/OC structures rely on excess spread as a form of credit enhancement. Such structures use the interest cash flow from assets in excess of the liability interest due (excess spread) to pay down bonds in order to offset losses on collateral. Credit enhancement is derived from a variety of sources, including excess spread and subordination. Proper valuation of each source of credit enhancement is essential to providing adequate loss protection for rated securities.
The updated cash flow modeling criteria will also affect the way net interest margin securities (NIMs) are analyzed and sized by Fitch. Excess spread that is not used to cover losses or build O/C is typically released to the residual certificate or class R certificate, which is used as collateral to back the NIM security. Thus, the amount of excess spread available for paying principal and interest to the NIMs is a function of Fitch's modeling assumptions, derivative cash flows, and other structural features.
For details on Fitch's criteria, see the two new criteria reports available at www.fitchratings.com:
-- 'U.S. RMBS Cash Flow Modeling Criteria'; and
-- 'U.S. Rating Criteria For Net Interest Margin Securities.'
The updated cash flow modeling assumptions are available in spreadsheet form under 'Cash Flow Modeling Assumptions-Revised' on the Fitch Ratings web site at www.fitchratings.com.
Fitch's rating definitions and the terms of use of such ratings are available on the agency's public site, www.fitchratings.com. Published ratings, criteria and methodologies are available from this site, at all times. Fitch's code of conduct, confidentiality, conflicts of interest, affiliate firewall, compliance and other relevant policies and procedures are also available from the 'Code of Conduct' section of this site.
- 5 Rules for Immediate Annuities
- Death in the Family: 12 Things to Do Now
- Dumbest Things You Do With Your Money
- 6 Online Networking Mistakes to Avoid
- 401(k) Mistakes to Avoid
- 5 Economic Scenarios to Keep You Up at Night
- The Real ‘Best Places to Retire’
- Best Credit Cards for You
- 12 Tough Questions to Ask Your Parents
- The Real ‘Best Colleges’
- Home Buyer Tax Credit: How to Cash In
- Why You Shouldn't Bash Cash
- 8 Phony 'Bargains' and Better Alternatives
- Danger: 3 Debit Card Scams to Avoid
- 6 Myths About Gas Mileage
- 29 Fees We Hate Most
- Quick and Easy Ways to Boost Returns
- Best Stocks to Buy Now
- Lower Your Taxes: 10 Moves to Make Now
- New Jobs: 8 Lessons from Real-Life Career Switchers
- The New Job Market: Who Wins and Who Loses?
- Health Care Reform's Public Option: Everything You Need to Know
- Volunteer Work When Unemployed: Should You Work for Free?
- Whose Recovery Is This?
- Long-Term-Care Insurance: 4 Biggest Risks to Avoid
Most Recent Business Articles
- Psyadon Pharmaceuticals, Inc. Announces Regulatory Milestones and the Initiation of a Clinical Trial of Ecopipam in Lesch-Nyhan Disease
- Emergence of “Femtomedicine” - New Frontier of Biomed Sciences - Reported at First Global Congress on Nano Medicine
- Research and Markets: Ethiopia Power Market Outlook to 2020
- Research and Markets: Orphan Drugs in Asia-Pacific: from Designation to Pricing, Funding & Market Access
- Research and Markets: Now You See It - TV Program Sponsorship & Product Placement in China
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FHM Features Anna Benson, Baseball's Hottest Wife
- Building a DNA database: the federal government has just enacted two bills related to DNA. The first would drive the collection of DNA from all infants. The second would attempt to prevent the DNA that is collected from being misused
- America's most wanted j-o-b-s - 10 hottest employment opportunities
- Developmental sequence in small groups


